STAT

Welcome to the first edition of the STAT Health Tech newsletter

STAT Health Tech is our weekly guide to how tech is transforming health care and the life sciences.

STAT Health Tech is our new weekly guide to how tech is transforming health care and the life sciences. Sign up here to receive it in your inbox every Wednesday.

Good morning. We’re thrilled to bring you the first edition of STAT Health Tech!

Every Wednesday, we’ll steer you through the crowded intersection of health care and technology. You’ll get the latest on how tech giants like Amazon and Alphabet and startups like Akili and Insitro are trying to disrupt the delivery of care and the development of drugs. And we’ll give you our take on the underlying financial, ethical, and privacy issues.

Why did we decide to launch a newsletter on this topic? Because advanced artificial intelligence and novel software tools are challenging the status quo in every corner of the industry. Our goal is not only to update you on the news, but also

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks